INSULIN GLULISINE (RECOMBINANT DNA ORIGIN) — all Canadian products
4 DINs
3 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is INSULIN GLULISINE (RECOMBINANT DNA ORIGIN), with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02279460 | APIDRA | SANOFI-AVENTIS CANADA INC | Solution | Subcutaneous | INSULIN GLULISINE (RECOMBINANT DNA ORIGIN) 100 UNIT | Marketed | |
| 02279479 | APIDRA | SANOFI-AVENTIS CANADA INC | Solution | Subcutaneous | INSULIN GLULISINE (RECOMBINANT DNA ORIGIN) 100 UNIT | Marketed | |
| 02294346 | APIDRA | SANOFI-AVENTIS CANADA INC | Solution | Subcutaneous | INSULIN GLULISINE (RECOMBINANT DNA ORIGIN) 100 UNIT | Marketed | |
| 02279487 | APIDRA | SANOFI-AVENTIS CANADA INC | Solution | Subcutaneous | INSULIN GLULISINE (RECOMBINANT DNA ORIGIN) 100 UNIT | Cancelled Pre Market |
Browse other molecules: